Document:

Form of Restricted Share Unit Rescission Agreement

 Exhibit 10.1 
 RESTRICTED SHARE UNIT RESCISSION AGREEMENT 
 This Restricted Share Unit
(“RSU”) Rescission Agreement (“Agreement”) is entered into by and between [director name] (the “Director”) and DCP Holding Company, an Ohio Corporation (the “Company”) as of the date executed by both parties,
as evidenced below. 
 RECITALS 
  

	1.	Pursuant to the 2006 Dental Care Plus Management Equity Incentive Plan (the “Plan”), the Director was granted an RSU Award (as defined in the Plan) with a
grant date of January 2, 2010, and vesting upon the Director’s attendance at a minimum of 75% of the regularly scheduled meetings of the Board of Directors in calendar year 2010 (the “2010 RSU Award”). 

 

	2.	The Compensation Committee of the Board of Directors of the Company has determined that all awards of RSUs to directors of the Company, including the Director, made as
of January 2, 2010, shall be rescinded in full. 

  

	3.	The Director is willing to agree to the rescission in full of the 2010 RSU Award, and is entering into this Agreement to consent to the rescission of the 2010 RSU Award
and to acknowledge that granting such consent is a free and voluntary act. 

 AGREEMENT 

Now, therefore, the Company and Director hereby agree as follows: 

The 2010 RSU Award granted to the Director is hereby rescinded and declared null, void and of no further effect, retroactively effective
as of the grant date thereunder. The Director agrees to surrender the RSU Agreement evidencing the 2010 RSU Award to the Company and that the Director shall not be entitled to any RSUs or Class B Shares of the Company based upon the 2010 RSU Award,
now or at any time hereafter. The Director also acknowledges that entering into this Agreement and surrendering the 2010 RSU Award is a free and voluntary act. 
  

									
	DCP Holding Company	 		 	Director:
				
	By:	 	  
	 		 	 X

					
	Title:	 	  
	 		 	Printed Name:	  	  

					
	Date:	 	  
	 		 	Date:Form of Underwriting Warrant

 Exhibit 10.1 
 THIS WARRANT MAY NOT BE SOLD, OFFERED FOR SALE, 
 PLEDGED, HYPOTHECATED OR
OTHERWISE TRANSFERRED. 
 STOCK PURCHASE WARRANT 

To Subscribe for and Purchase 
 Common Stock of 
 ENTEROMEDICS INC. 

THIS CERTIFIES THAT, for value received, Craig-Hallum Capital Group LLC, or its registered assigns, (herein referred to as the
“Purchaser” or “holder”), is entitled to subscribe for and purchase from EnteroMedics Inc. (herein called the “Company”), a corporation organized and existing under the laws of the State of
Delaware, Three Hundred Forty Thousand Four Hundred (340,400) fully paid and nonassessable shares (“Shares”) of common stock (herein the “Common Stock”) (subject to the limitation in Section 2(b) and to
adjustment as noted below) at the exercise price of $2.19 per Share (the “Warrant Purchase Price”) (subject to adjustment as noted below). This Warrant may only be exercised during the Exercise Period specified herein. This Warrant
has been issued together with Shares of the Common Stock in a public offering of 14,800,000 Shares of the Common Stock and 14,800,000 Warrants registered on the Company’s Registration Statements on Form S-1 (the “Registration
Statement”) filed with the U.S. Securities and Exchange Commission (the “SEC”) on November 10, 2010, as amended and December 8, 2010 (the “Offering”). 

This Warrant is subject to the following provisions, terms and conditions: 

1. The Warrant exercise period (the “Exercise Period”) for this Warrant shall begin on the date that is 181 days from
the date of the issuance of this Warrant at the closing of the Offering and shall end on the fifth anniversary of the date of effectiveness of the Registration Statement. 
 2. The rights represented by this Warrant may be exercised by the holder hereof as follows: 
 (a) The rights represented by this Warrant may be exercised by the holder hereof, in whole or in part, by written notice of exercise delivered to the Company and by the surrender of this Warrant (properly
endorsed if required) at the principal office of the Company and upon payment to it by check of the Warrant Purchase Price for such Shares. The Company agrees that the Shares so purchased shall be and are deemed to be issued to the holder hereof as
the record owner of such Shares as of the close of business on the date on which this Warrant shall have been surrendered and payment made for such Shares as aforesaid. Subject to the provisions of the next succeeding paragraph, within 10 business
days after the rights represented by this Warrant shall have been exercised the Company shall cause its transfer agent to issue the Shares of stock so purchased to Purchaser in book–entry format and deliver evidence of such issuance to
Purchaser, and, unless this Warrant has expired, a new Warrant representing the number of Shares, if any, with respect to which this Warrant shall not then have been exercised shall also be delivered to the holder hereof within such time.

 (b) Notwithstanding any other provision in this Warrant, no holder shall be
permitted to exercise this Warrant for an amount of Common Stock that would result in such holder owning more than 19.99% of the Company’s Common Stock outstanding after such exericise. 

3. The Company represents and warrants that this Warrant has been duly authorized by all necessary corporate action, has been duly
executed and delivered and is a legal and binding obligation of the Company, enforceable against the Company in accordance with the terms of this Warrant, except to the extent (i) such enforceability may be limited by applicable bankruptcy,
insolvency, reorganization, moratorium or similar laws affecting creditors’ and contracting parties’ rights generally and (ii) such enforceability may be subject to general principles of equity (regardless of whether such
enforceability is considered in a proceeding in equity or at law). The Company covenants and agrees that all Shares which may be issued upon the exercise of the rights represented by this Warrant according to the terms hereof or represented by the
Common Stock will, upon issuance and payment therefor, be duly authorized and issued, fully paid and nonassessable. The Company further covenants and agrees that during the period within which the rights represented by this Warrant may be exercised,
the Company will at all times have authorized, and reserved for the purpose of issue or transfer upon exercise of the subscription rights evidenced by this Warrant, a sufficient number of shares of its Common Stock to provide for the exercise of the
rights represented by this Warrant, free from preemptive rights or other actual contingent purchase rights other than those held by a holder of this Warrant (as a result of holding this Warrant). 

4. The Company will pay any documentary stamp taxes attributable to the issuance of Shares of Common Stock upon the exercise of this
Warrant; provided, however, that the Company shall not be required to pay any tax which may be payable in respect of any transfer involved in the registration of any certificates for Warrants, or shares of Common Stock issued upon exercise of
this Warrant, in a name other than that of the Purchaser. The Purchaser shall be responsible for all other tax liability that may arise as a result of holding or transferring this Warrant or receiving Shares of Common Stock upon exercise hereof.

 5. The above provisions are, however, subject to the following: 

(a) The Warrant Purchase Price shall, from and after the date of issuance of this Warrant, be subject to adjustment from
time to time as hereinafter provided. Upon each adjustment of the Warrant Purchase Price, the holder of this Warrant shall thereafter be entitled to purchase, at the Warrant Purchase Price resulting from such adjustment, the number of Shares
obtained by multiplying the Warrant Purchase Price in effect immediately prior to such adjustment by the number of Shares purchasable pursuant hereto immediately prior to such adjustment and dividing the product thereof by the warrant purchase price
resulting from such adjustment. 
 (b) In case the Company shall at any time subdivide its outstanding shares of
Common Stock into a greater number of shares, the Warrant Purchase Price in effect 

  
 2 

 
immediately prior to such subdivision shall be proportionately reduced, and conversely, in case the outstanding shares of Common Stock of the Company shall be combined into a smaller number of
shares, the Warrant Purchase Price in effect immediately prior to such combination shall be proportionately increased. 
 (c) If any capital reorganization or reclassification of the capital stock of the Company, shall be effected in such a way that holders of Common Stock shall be entitled to receive stock or securities
with respect to or in exchange for Common Stock, then, as a condition of such reorganization, reclassification or consolidation, lawful and adequate provision shall be made whereby the holder hereof shall thereafter have the right to purchase and
receive, upon the basis and upon the terms and conditions specified in this Warrant and in lieu of the Shares of the Common Stock of the Company immediately theretofore purchasable and receivable upon the exercise of the rights represented hereby,
such shares of stock or securities as may be issued or payable with respect to or in exchange for a number of outstanding shares of such Common Stock equal to the number of shares of such stock immediately theretofore purchasable and receivable upon
the exercise of the rights represented hereby had such reorganization, reclassification or consolidation not taken place, and in any such case appropriate provision shall be made with respect to the rights and interests of the holder of this Warrant
to the end that the provisions hereof (including without limitation provisions for adjustments of the warrant purchase price and of the number of shares purchasable upon the exercise of this Warrant) shall thereafter be applicable, as nearly as may
be, in relation to any shares of stock or securities thereafter deliverable upon the exercise hereof. 
 (d) Upon
any adjustment of the Warrant Purchase Price or any adjustment of any material terms hereof, then and in each such case an officer of the Company shall, as soon as practicable after the occurrence of any event that requires an adjustment or
readjustment, give signed written notice thereof, by first–class mail, postage prepaid, addressed to the registered holder of this Warrant at the address of such holder as shown on the books of the Company, which notice shall state the Warrant
Purchase Price resulting from such adjustment, any material change in the terms of the Warrant, and the increase or decrease, if any, in the number of Shares purchasable at such price upon the exercise of this Warrant, setting forth in reasonable
detail the method of calculation and the facts upon which such calculation is based. 
 (e) In case any time:

 (i) there shall be any capital reorganization, or reclassification of the capital stock of the Company; or

 (ii) there shall be a voluntary or involuntary dissolution, liquidation or winding up of the Company;

 then, in any one or more of said cases, the Company shall give written notice, by first–class mail,
postage prepaid, addressed to the registered holder of this Warrant at the address of such holder as shown on the books of the Company, of the date on which (A) the books of the Company shall close or a record shall be

  
 3 

 
taken for such distribution or subscription rights, or (B) such reorganization, reclassification or consolidation, dissolution, liquidation or winding up, or conversion or redemption shall
take place, as the case may be. Such notice shall also specify the date as of which the holders of capital stock of record shall participate in such distribution or subscription rights, or shall be entitled to exchange their capital stock for
securities or other property deliverable upon such reorganization, reclassification, consolidation, dissolution, liquidation or winding up, or conversion or redemption, as the case may be. Such written notice shall be given at least 20 days prior to
the action in question and not less than 20 days prior to the record date or the date on which the Company’s transfer books are closed in respect thereto. 
 (f) If any event occurs as to which in the opinion of the Board of Directors of the Company the other provisions of this Section 5 are not strictly applicable or if strictly applicable would not
fairly protect the purchase rights of the holder of this Warrant or of Common Stock in accordance with the essential intent and principles of such provisions, then the Board of Directors shall make an adjustment in the application of such
provisions, in accordance with such essential intent and principles, so as to protect such purchase rights as aforesaid. 
 6.
This Warrant shall not entitle the holder hereof to any voting rights or other rights as a stockholder of the Company. 
 7.
This Warrant may not be sold, offered for sale, pledged, hypothecated or otherwise transferred and must be held by the Purchaser until it is exercised for Shares of Common Stock in accordance with paragraphs 1 and 2 above. In addition, without
limiting the first sentence of this Section 7, pursuant to Rule 5110(g) of the Financial Industry Regulatory Authority, Inc., this Warrant shall not be sold during the Offering, or sold, transferred, assigned, pledged, or hypothecated, or be
the subject of any hedging, short sale, derivative, put, or call transaction that would result in the effective economic disposition of this Warrant or the Shares of Common Stock acquirable upon exercise hereof, by any person for a period of 180
days immediately following the date of effectiveness or commencement of sales of the Offering, except as provided in paragraph (g)(2) of Rule 5110(g) of the Financial Industry Regulatory Authority, Inc. 

8. This Warrant is exchangeable, upon the surrender hereof by the holder hereof at the principal office of the Company, for new Warrants
of like tenor representing in the aggregate the right to subscribe for and purchase the number of shares which may be subscribed for and purchased hereunder, each of such new Warrants to represent the right to subscribe for and purchase such number
of shares as shall be designated by said holder hereof at the time of such surrender. 
 9. This Warrant has been registered
with the SEC and qualified by state authorities, or an exemption from such registration and qualification requirements is available. The Shares of Common Stock issuable upon exercise of the Warrant may be transferred and sold in reliance on the
Registration Statement. Pursuant to Section 4(t) of the Purchase Agreement, dated December 8, 2010, between the Company and Craig-Hallum Capital Group LLC (the “Purchase 

  
 4 

 
Agreement”), the Company will, at its own expense, prepare and file with the SEC, and keep effective with the SEC, a registration statement with respect to the Shares of Common Stock
issuable upon exercise of this Warrant such that the holder hereof may exercise this warrant and a holder of the Shares of Common Stock acquired upon exercise hereof may resell such Shares to the public for a period of time at least equal to the
Exercise Period plus two years following the expiration date thereof. The Company and the holder acknowledge and agree that the Company’s obligation relating to the registration of the Shares of Common Stock issuable upon exercise of this
Warrant pursuant to this Section 9 and Section 4(t) of the Purchase Agreement is a one-time obligation, and that holder’s countersignature to this Warrant upon its issuance constitutes holder’s one-time exercise of such
registration rights. 
 10. The Company will not be required upon the exercise of this Warrant to issue fractions of shares of
Common Stock, but may, at its option, either (a) purchase such fraction for an amount in cash equal to the current value of such fraction computed on the basis of the closing market price of a share of Common Stock as quoted on the principal
exchange or trading facility on which shares of Common Stock are traded on the trading day immediately preceding the day upon which this Warrant was surrendered for exercise in accordance with Section 2 hereof, or (b) issue the required
share. By accepting this Warrant, the holder hereof expressly waives any right to receive any fractional share upon exercise of a Warrant, except as expressly provided in this Section 10. 

11. If this Warrant is exercised for less than all of the then-current number of shares purchasable hereunder, then the Company shall,
concurrently with the issue of the Shares of stock purchased by Purchaser upon such exercise in accordance with Section 2, issue a new warrant exercisable for the remaining number of shares purchasable under this Warrant. 

12. Upon receipt by the Company of evidence reasonably satisfactory to it of the loss, theft, destruction or mutilation of this Warrant
and security reasonably satisfactory to it, the Company shall execute and deliver a new warrant of like tenor as the Warrant so lost, stolen, destroyed or mutilated. 
 13. All questions concerning this Warrant will be governed and interpreted and enforced in accordance with the internal law, not the law of conflicts, of the State of Delaware. 

[remainder of this page intentionally left blank] 

  
 5 

 IN WITNESS WHEREOF, EnteroMedics Inc. has caused this Warrant to be signed by its duly
authorized officer and this Warrant to be dated as of the date set forth above. 
  

					
	ENTEROMEDICS INC.
		
	By	 	  

		 	Its	 	  

 

			
	Acknowledged and agreed:
	
	Craig-Hallum Capital Group LLC
		
	By	 	  

	Name	 	  

	Its	 	  

 SUBSCRIPTION FORM 

To be Executed by the Holder of this Warrant if such Holder 
 Desires to Exercise this Warrant in Whole or in Part 
  

	To:	EnteroMedics Inc. (the “Company”) 

 The undersigned
                                         
                    

Please insert Social Security or other 
 identifying number of Subscriber: 
  

 
 hereby irrevocably elects to
exercise the right of purchase represented by this Warrant for, and to purchase thereunder,              shares of the Common Stock (the “Common Stock”) provided for
therein and tenders payment herewith to the order of the Company in the amount of $            , such payment being made as provided on the face of this Warrant. 

The undersigned requests that certificates for such shares of Common Stock be issued as follows: 

 

			
	 Name:
	  	  

			
		
	 Address:
	  	  

			
		
	 Deliver to:
	  	  

			
		
	 Address:
	  	  

 and, if such number of shares of Common Stock shall not be all the shares of Common Stock purchasable hereunder, that a new Warrant for the balance remaining of the shares of Common Stock purchasable
under this Warrant be registered in the name of, and delivered to, the undersigned at the address stated above. 
 Dated:
                         

 

			
	Signature	 	  

		 	Note: The signature on this Subscription Form must correspond with the name as written upon the face of this Warrant in every particular, without alteration or enlargement or any
change whatever.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00182-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00182-of-00352.parquet"}]]